Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

NCT00596596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: prucalopride
DRUG: prucalopride
DRUG: 2 mg prucalopride
DRUG: 4 mg prucalopride
OTHER: Placebo

Sponsor

Movetis